The Studies · updated 2026-06-12
The Studies
The longevity market runs on studies few people read past the headline. We read the paper, the design, the dose and the conflict line. Each piece asks the same buyer question: does this study support the product being sold to you, or only the headline?
Does hyperbaric oxygen reverse aging? What the telomere study actually showed
A real, peer-reviewed signal at a clinical dose you cannot buy, in a tiny sample with no control arm for the telomere result, from a team that sells the treatment. Intriguing, not settled, and not what a home chamber delivers.
Read the fact-check →Should healthy people wear a CGM? What OTC clearance actually changed
OTC clearance made CGMs easier to buy; it did not prove that healthy people need a monthly glucose feed. Useful as a two-week audit for prediabetes or a specific diet question, weak as an open-ended subscription for the worried well.
Read the fact-check →Do weighted vests build bone? The claim survives only in a narrow lane
A useful load-adder, not a bone-density guarantee. The best case is an adjustable vest used during controlled walking, stairs or bodyweight work; the weak case is buying one instead of lifting, jumping or getting a DEXA scan.
Read the fact-check →The Agewell Briefing
The longevity news worth your time, once a week.
A sourced weekly read on longevity products, clinics and research, with a clear answer on what is worth trying.
One email a week. Unsubscribe with one click.